1	G.D.	_	NNP	_	_	2	NAME	_	_
2	Searle	_	NNP	_	_	5	SBJ	_	_
3	&	_	CC	_	_	2	COORD	_	_
4	Co.	_	NNP	_	_	3	CONJ	_	_
5	said	_	VBD	_	_	0	ROOT	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	Food	_	NNP	_	_	11	SBJ	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	Drug	_	NNP	_	_	10	NAME	_	_
10	Administration	_	NNP	_	_	8	CONJ	_	_
11	approved	_	VBD	_	_	5	OBJ	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	sale	_	NN	_	_	11	OBJ	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	Kerlone	_	NNP	_	_	14	PMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	a	_	DT	_	_	19	NMOD	_	_
18	hypertension	_	NN	_	_	19	NMOD	_	_
19	drug	_	NN	_	_	15	APPO	_	_
20	developed	_	VBN	_	_	19	APPO	_	_
21	by	_	IN	_	_	20	LGS	_	_
22	a	_	DT	_	_	24	NMOD	_	_
23	joint	_	JJ	_	_	24	NMOD	_	_
24	venture	_	NN	_	_	21	PMOD	_	_
25	between	_	IN	_	_	24	NMOD	_	_
26	Searle	_	NNP	_	_	25	PMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	a	_	DT	_	_	30	NMOD	_	_
29	French	_	JJ	_	_	30	NMOD	_	_
30	concern	_	NN	_	_	27	CONJ	_	_
31	.	_	.	_	_	5	P	_	_

1	Searle	_	NNP	_	_	9	SBJ	_	_
2	,	_	,	_	_	1	P	_	_
3	a	_	DT	_	_	4	NMOD	_	_
4	unit	_	NN	_	_	1	APPO	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	Monsanto	_	NNP	_	_	5	PMOD	_	_
7	Co.	_	NNP	_	_	6	POSTHON	_	_
8	,	_	,	_	_	1	P	_	_
9	said	_	VBD	_	_	0	ROOT	_	_
10	the	_	DT	_	_	16	NMOD	_	_
11	``	_	``	_	_	16	P	_	_
12	beta-blocker	_	NN	_	_	16	NMOD	_	_
13	''	_	''	_	_	16	P	_	_
14	high-blood-pressure	_	JJ	_	_	16	NMOD	_	_
15	drug	_	NN	_	_	16	NMOD	_	_
16	Kerlone	_	NNP	_	_	17	SBJ	_	_
17	is	_	VBZ	_	_	9	OBJ	_	_
18	the	_	DT	_	_	20	NMOD	_	_
19	first	_	JJ	_	_	20	NMOD	_	_
20	product	_	NN	_	_	17	PRD	_	_
21	to	_	TO	_	_	20	NMOD	_	_
22	reach	_	VB	_	_	21	IM	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	market	_	NN	_	_	22	OBJ	_	_
25	through	_	IN	_	_	22	ADV	_	_
26	Lorex	_	NNP	_	_	27	NAME	_	_
27	Pharmaceuticals	_	NNP	_	_	25	PMOD	_	_
28	,	_	,	_	_	27	P	_	_
29	the	_	DT	_	_	31	NMOD	_	_
30	U.S.	_	NNP	_	_	31	NMOD	_	_
31	company	_	NN	_	_	27	APPO	_	_
32	jointly	_	RB	_	_	33	ADV	_	_
33	owned	_	VBN	_	_	31	APPO	_	_
34	by	_	IN	_	_	33	LGS	_	_
35	Searle	_	NNP	_	_	34	PMOD	_	_
36	and	_	CC	_	_	35	COORD	_	_
37	Synthelabo	_	NNP	_	_	36	CONJ	_	_
38	,	_	,	_	_	37	P	_	_
39	a	_	DT	_	_	42	NMOD	_	_
40	French	_	JJ	_	_	42	NMOD	_	_
41	pharmaceutical	_	JJ	_	_	42	NMOD	_	_
42	concern	_	NN	_	_	37	APPO	_	_
43	owned	_	VBN	_	_	42	APPO	_	_
44	by	_	IN	_	_	43	LGS	_	_
45	France	_	NNP	_	_	47	NMOD	_	_
46	's	_	POS	_	_	45	SUFFIX	_	_
47	L'Oreal	_	NNP	_	_	44	PMOD	_	_
48	S.A	_	NNP	_	_	47	POSTHON	_	_
49	.	_	.	_	_	9	P	_	_

